BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 62.36%-184.37M | ---- | 88.31%-489.78M | ---- | -226.53%-4.19B | ---- | -146.34%-1.28B | ---- | ---521.03M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -190.35%-108.02M | ---- | -473.25%-37.2M | ---- | -169.63%-6.49M | ---- | -1,583.22%-2.41M | ---- | ---143K |
Impairment and provisions: | ---- | --5.43M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | --5.43M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | -329.98%-136.24M | ---- | -100.89%-31.69M | ---- | 872.67%3.55B | ---- | -7.79%365.39M | ---- | --396.28M |
-Other fair value changes | ---- | -329.98%-136.24M | ---- | -100.89%-31.69M | ---- | 872.67%3.55B | ---- | -7.79%365.39M | ---- | --396.28M |
Depreciation and amortization: | ---- | -7.97%15.67M | ---- | -1.33%17.03M | ---- | 21.49%17.26M | ---- | 89.63%14.21M | ---- | --7.49M |
-Amortization of intangible assets | ---- | -43.54%1.76M | ---- | 14.84%3.12M | ---- | 100.00%2.72M | ---- | --1.36M | ---- | ---- |
Financial expense | ---- | -41.95%494K | ---- | -27.57%851K | ---- | -29.56%1.18M | ---- | 49.87%1.67M | ---- | --1.11M |
Exchange Loss (gain) | ---- | -96.91%1.35M | ---- | --43.58M | ---- | ---- | ---- | ---- | ---- | ---- |
Special items | ---- | -186.73%-67.59M | ---- | -1.82%77.93M | ---- | 169.21%79.37M | ---- | 26.10%29.48M | ---- | --23.38M |
Operating profit before the change of operating capital | ---- | -12.88%-473.28M | ---- | 23.17%-419.29M | ---- | 37.64%-545.72M | ---- | -841.98%-875.17M | ---- | ---92.91M |
Change of operating capital | ||||||||||
Accounts payable increase (decrease) | ---- | -40.11%-81.46M | ---- | 79.71%-58.14M | ---- | -160.01%-286.62M | ---- | 6,379.24%477.59M | ---- | --7.37M |
prepayments (increase)decrease | ---- | -111.85%-33.14M | ---- | 37.87%-15.65M | ---- | -4.85%-25.18M | ---- | -556.08%-24.02M | ---- | ---3.66M |
Cash from business operations | ---- | -19.23%-587.89M | ---- | 42.50%-493.07M | ---- | -103.40%-857.52M | ---- | -372.66%-421.6M | ---- | ---89.2M |
Special items of business | 36.17%-225.79M | -90.99%-6.13M | -31.54%-353.76M | 85.38%-3.21M | 55.32%-268.94M | -222.68%-21.94M | -184.25%-601.96M | -18.42%17.88M | ---211.77M | --21.92M |
Net cash from operations | 36.17%-225.79M | -19.69%-594.01M | -31.54%-353.76M | 43.57%-496.28M | 55.32%-268.94M | -117.84%-879.46M | -184.25%-601.96M | -500.09%-403.72M | ---211.77M | ---67.28M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 12.84%26.28M | 208.75%106.96M | 125.20%23.29M | 2,034.44%34.64M | 1,568.23%10.34M | -32.57%1.62M | -31.79%620K | 1,583.22%2.41M | --909K | --143K |
Restricted cash (increase) decrease | ---90.29M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | 218.83%452.22M | 75.10%-336.2M | -255.83%-380.57M | -183.57%-1.35B | 942.14%244.22M | -1,932.48%-476.21M | 122.59%23.43M | ---23.43M | ---103.74M | ---- |
Purchase of fixed assets | ---765K | ---- | ---- | ---- | ---- | ---1.03M | ---1.77M | ---- | ---- | ---24.15M |
Purchase of intangible assets | ---- | 64.39%-49.61M | ---- | ---139.29M | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 67.24%6.47M | 539.84%140.06M | 278.01%3.87M | 20,357.94%21.89M | 1,905.88%1.02M | -94.86%107K | -97.53%51K | -59.14%2.08M | --2.06M | --5.1M |
Cash on investment | ---- | ---21.59M | ---- | ---- | ---- | 99.00%-248K | ---- | 66.55%-24.71M | ---18.59M | ---73.87M |
Other items in the investment business | ---- | --56.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 211.46%393.91M | 92.72%-104.35M | -238.28%-353.41M | -201.24%-1.43B | 1,044.36%255.58M | -989.93%-475.76M | 118.71%22.33M | 52.95%-43.65M | ---119.36M | ---92.78M |
Net cash before financing | 123.77%168.12M | 63.80%-698.36M | -5,192.40%-707.17M | -42.37%-1.93B | 97.69%-13.36M | -202.93%-1.36B | -75.04%-579.63M | -179.50%-447.37M | ---331.13M | ---160.06M |
Cash flow from financing activities | ||||||||||
Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---200K |
Issuing shares | -66.92%43K | -97.60%179K | -95.83%130K | -99.78%7.45M | -99.69%3.12M | 397.76%3.33B | 1,643,268.85%1B | 27.41%668.53M | --61K | --524.7M |
Interest paid - financing | -289.37%-989K | 41.95%-494K | 47.08%-254K | 27.57%-851K | 46.25%-480K | 29.56%-1.18M | -7.07%-893K | -45.30%-1.67M | ---834K | ---1.15M |
Issuance expenses and redemption of securities expenses | ---- | -71.39%-1.16M | ---- | 99.22%-678K | ---- | -2,719.07%-86.63M | ---620K | ---3.07M | ---- | ---- |
Net cash from financing operations | 7.53%-4.42M | -260.85%-10.98M | -217.74%-4.78M | -100.09%-3.04M | -100.15%-1.51M | 391.65%3.23B | 22,167.15%996.99M | 26.75%657M | ---4.52M | --518.35M |
Effect of rate | -67.23%2.91M | -96.86%8.42M | -92.96%8.87M | 589.06%267.97M | 1,776.68%125.97M | 0.43%-54.79M | -197.09%-7.51M | -5,892.53%-55.03M | --7.74M | --950K |
Net Cash | 122.99%163.7M | 63.29%-709.34M | -4,688.81%-711.95M | -203.07%-1.93B | -103.56%-14.87M | 794.37%1.87B | 224.34%417.36M | -41.49%209.64M | ---335.65M | --358.29M |
Begining period cash | -58.87%489.65M | -58.30%1.19B | -58.30%1.19B | 175.86%2.86B | 175.86%2.86B | 17.56%1.03B | 17.56%1.03B | 68.94%880.36M | --880.36M | --521.12M |
Cash at the end | 34.62%656.26M | -58.87%489.65M | -83.57%487.49M | -58.30%1.19B | 105.30%2.97B | 175.86%2.86B | 161.53%1.44B | 17.56%1.03B | --552.45M | --880.36M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.